Biosante Pharmaceuticals Aktie

Kaufen
Verkaufen
51,00 EUR ±0,00 EUR ±0,00 %
54,18 USD +0,01 USD +0,02 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 1,09 Mrd. EUR

KGV 58,49 Div. Rendite 0,00%

WKN A1W15D

ISIN US00182C1036

Symbol ANIP


Biosante Pharmaceuticals Aktie Analyse

16.10.17 Biosante Pharmaceuticals Buy Canaccord Adams
31.07.17 Biosante Pharmaceuticals Buy Canaccord Adams
24.05.16 Biosante Pharmaceuticals Hold Standpoint Research
13.11.15 Biosante Pharmaceuticals Buy Standpoint Research
28.09.15 Biosante Pharmaceuticals Buy ROTH Capital Partners, LLC
05.08.15 Biosante Pharmaceuticals Outperform Oppenheimer & Co. Inc.
04.08.15 Biosante Pharmaceuticals Neutral ROTH Capital Partners, LLC
31.07.15 Biosante Pharmaceuticals Outperform Oppenheimer & Co. Inc.
15.07.15 Biosante Pharmaceuticals Neutral ROTH Capital Partners, LLC
23.06.15 Biosante Pharmaceuticals Outperform Oppenheimer & Co. Inc.
18.05.15 Biosante Pharmaceuticals Neutral ROTH Capital Partners, LLC
06.05.15 Biosante Pharmaceuticals Outperform Oppenheimer & Co. Inc.
10.04.15 Biosante Pharmaceuticals Neutral ROTH Capital Partners, LLC
26.02.15 Biosante Pharmaceuticals Buy ROTH Capital Partners, LLC
18.02.15 Biosante Pharmaceuticals Outperform Oppenheimer & Co. Inc.
20.11.14 Biosante Pharmaceuticals Buy ROTH Capital Partners, LLC